Filter
3011
Filtered Results: 3011
Text search:
Emerging
Infectious
Diseases
Featured
Recommendations
312
New Publications
689
Language
Document type
No document type
1317
Studies & Reports
670
Guidelines
536
Strategic & Response Plan
173
Manuals
147
Fact sheets
78
Training Material
34
Situation Updates
27
Resource Platforms
10
Online Courses
8
Infographics
6
Brochures
2
Videos
2
App
1
Countries / Regions
Global
184
India
103
Kenya
88
Sierra Leone
76
Africa
63
Liberia
61
South Africa
58
Western and Central Europe
56
Ethiopia
56
Uganda
52
Nigeria
47
Malawi
44
Latin America and the Carribbean
44
Nepal
37
Ghana
36
Tanzania
34
Rwanda
33
Zambia
32
Guinea
30
Namibia
29
Bangladesh
28
South–East Asia Region
26
Philippines
24
Asia
23
Brazil
23
Eastern Europe
22
Myanmar / Burma
22
Syria
21
Congo, Democratic Republic of
21
Russia
20
West and Central Africa
18
East and Southern Africa
18
Lesotho
17
Zimbabwe
17
Germany
17
Mozambique
16
Cambodia
16
Middle East and North Africa
16
South Sudan
16
Ukraine
15
Haiti
14
Eastern Europe and Central Asia
14
Senegal
13
Pakistan
12
Western Pacific Region
11
Botswana
11
Thailand
10
Venezuela
10
Vietnam
10
Indonesia
10
Cameroon
9
Burkina Faso
9
Angola
8
Eswatini/ Swaziland
8
Colombia
7
China
7
Yemen
7
USA
6
Sudan
5
Mali
5
Somalia
5
Turkey
4
Laos
4
Guinea-Bissau
4
Jordan
4
France
4
Côte d’Ivoire / Ivory Coast
4
Papua New Guinea
4
Central African Republic
4
North Macedonia
3
Tajikistan
3
Iran
3
Niger
3
Peru
3
Saudi Arabia
3
Spain
3
Lebanon
3
Moldova
3
Georgia
3
Ecuador
3
Timor Leste/ East Timor
2
Benin
2
Chile
2
Albania
2
Afghanistan
2
Burundi
2
Paraguay
2
North America
2
Turkmenistan
2
Mauritius
2
Southern Africa
2
Bolivia
2
Argentina
2
Sri Lanka
2
Honduras
2
Chad
2
Iraq
2
El Salvador
1
Gambia
1
Togo
1
Kazakhstan
1
Canada
1
Singapore
1
Congo-Brazzaville
1
Uzbekistan
1
Morocco
1
Qatar
1
Bulgaria
1
Lithuania
1
Gabon
1
Japan
1
Denmark
1
Maldives
1
Tunisia
1
United Kingdom
1
Portugal
1
Egypt
1
Greece
1
Palestine
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
997
Clinical Guidelines
229
Public Health
177
Key Resources
150
Women & Child Health
98
Capacity Building
45
Pharmacy & Technologies
38
Annual Report MEDBOX
2
Toolboxes
COVID-19
457
HIV
225
AMR
186
Planetary Health
174
TB
151
Ebola & Marburg
130
NTDs
125
Rapid Response
109
Mental Health
103
Global Health Education
74
2.0 Rapid Response
65
Caregiver
58
Health Financing Toolbox
57
Zika
52
Malaria
50
NCDs
41
Natural Hazards
40
Conflict
39
Pharmacy
36
Disability
26
Cholera
23
Polio
23
Refugee
20
Specific Hazards
9
Social Ethics
3
South Sudan
2
Full Report.
In response to a call by the United Nations Secretary-General and the Governments of Guinea, Liberia and Sierra Leone, an international team conducted an Ebola Recovery Assessment. The aim was to contribute towards laying the foundation for short-, medium- and long-term recovery while ...
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance and case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to ...
Healthy people, healthy animals and a healthy environment worldwide with the One Health approach.
The COVID-19 pandemic has drastically demonstrated just how close the link is between humans, animals, and the environment, and has highlighted and aggravated existing challenges. The destruction of na...
Updated 6 September 2016. This guidance has been developed to provide advice on the prevention of potential sexual transmission of Zika virus. The primary transmission route of Zika virus is via the Aedes mosquito. However, sexual transmission of Zika virus may also be possible, with limited evidenc...
The World Health Organization (WHO) and United NationsHuman Settlements Programme (UN-HABITAT) joint globalreport, Hidden cities: unmasking and overcoming healthinequities in urban settings, exposes the extent to whichcertain city dwellers suffer disproportionately from a wide range of diseases and ...
9 June 2021
Since its launch, GLASS has expanded in scope and coverage and as of May 2021, 109 countries and territories worldwide have enrolled in GLASS. A key new component in GLASS is the inclusion of antimicrobial consumption (AMC) surveillance at the national level highlighted in this fourth G...
Antimicrobial resistance (AMR) both in human and veterinary medicine has reached alarming levels in
most parts of the world and has now been recognized as a significant emerging threat to global public
health and food security. In June 2015, the Food and Agriculture Organization of the United Nati...
Building on our decades of commitment to human rights in medicine and healthcare, we have published a new report on emerging threats in health-related human rights both globally and in the UK.
'Health and human rights in the new world (dis)order' outlines a shifting rights landscape in which new ...
The Global vector control response 2017–2030 (GVCR) provides a new strategy to strengthen vector control worldwide through increased capacity, improved surveillance, better coordination and integrated action across sectors and diseases.
In May 2017, the World Health Assembly adopted resolutio...
In May 2017, the World Health Assembly adopted resolutio...
The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality...
At the time of writing, the novel coronavirus pandemic had reached every region of the world, with millions of infections globally and untold disruptions to nearly every aspect of daily life.
How to address the global crisis in antibiotic research and development.
The report includes a comprehensive summary and critical evaluation of recent initiatives to overcome the barriers to achieve sustainable access to antibiotics. As antibiotic resistance will continue to develop as long as we ...
The extensive use of antimicrobials in human and veterinary medicine in recent years has accelerated the emergence and spread of resistant microorganisms. This situation has been worsened by the lack of investment in developing new effective antibiotics. The severity of the consequences is clear to ...
The WHO country office for Ghana, began the year 2019 with a 4-day staff retreat at the Busua Beach Resort in the Western Region from 04 to 08 March 2019. The theme for the retreat was ‘Impacting the Health and Lives of the people of Ghana through the Triple Billion Goal”. The staff outlined pri...
The purpose of this guidance is to assist WHO Member States, and other stakeholders, in the establishment and development of programmes of integrated surveillance of antimicrobial resistance in foodborne bacteria (i.e., bacteria commonly transmitted by food). In this guidance, “integrated surveill...
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant...
A guide to increasing coverage and equity in all communities in the African Region
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
Expanded Programs on Immunization (EPI) is responsible for vaccines and vaccination to control, eliminate and eradicate vaccine preventable diseases (VPDs). Having strong immunization systems to deliver vaccines ...
This Interim Guidance outlines how key public health and social measures needed to reduce the risk of COVID-19 spread and the impact of the disease can be adapted for use in low capacity and humanitarian settings. The recommendations outlined here need to be adjusted to the scale of transmission, co...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
The waves of yellow fever transmission in the Region of the Americas in 2016–2018 involved the largest number of human and epizootic cases to be reported in several decades. Yellow fever is a serious viral hemorrhagic disease that poses a challenge for health professionals. It requires early recog...
